
|Articles|August 1, 2003
Study supports limiting off-label fluoroquinolone use
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy
2
New sunscreen ingredient clears FDA for the first time since the 1990s
3
FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease
4
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
5


